Track topics on Twitter Track topics that are important to you
38 Sidney Street
United States of America
Phone: 001 (617) 761 4200
Fax: 001 (617) 494 1741
This study is to assess the safety and immunogenicity of three consecutive lots of JE-CV in toddlers aged 12-18 months. Primary objective: To demonstrate the bio-equivalence of thr...
Acambis recognises the value of highly focused marketing efforts and is initially targeting the world's single largest vaccine market – the US – to maximise the return on our investment. In 2003, ...
Acambis is a biopharmaceutical company discovering, developing and manufacturing vaccines to prevent and treat infectious diseases. Employing some 160 people, it is based in Cambridge, UK, and Cambrid...
Avlar was founded in 1999 by Alan Goodman and Daniel Roach and manages Avlar Fund I (£21m) and Avlar Fund II (£43m). Avlar has invested in eighteen companies across a range of sub-sectors of the bio...
Implicit Bioscience Pty Ltd is an immunology-focused drug development company headquartered in Brisbane, Australia; Implicit's US subsidiary, Implicit Bioscience, Inc., is located on the San Francisco...
We have published hundreds of Acambis news stories on BioPortfolio along with dozens of Acambis Clinical Trials and PubMed Articles about Acambis for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Acambis Companies in our database. You can also find out about relevant Acambis Drugs and Medications on this site too.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one ...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...